ALFA Finder| Revenue growth | 32% YoY growth to ₹110.7 crore in FY26. |
|---|---|
| Margins | EBITDA margins expanded significantly to 20.4%. |
| Demand visibility | Strong traction in textiles and high growth in home/personal care. |
| Management confidence | Optimistic, highlighting successful brand transition and specialty chemical scaling. |
Growth
Revenue grew 32% YoY to ₹110.7 crore, while EBITDA margins jumped 321 bps to 20.4% due to better product mix.
Outlook
Targeting ₹250 crore revenue by FY28 at 85% capacity utilization with 18-20% EBITDA margins.
Risks
High receivables (161 days) and geopolitical volatility affecting raw material costs and Bangladesh exports remain key concerns.
Earnings Call filed with NSE, NSE: NEOCHEM. Summary written with AI assistance from the document.
Neochem Bio Solutions Ltd: key numbers
- Share price
- ₹111.00
- Market cap
- ₹190.0 Cr
- Revenue (annual)
- ₹110.7 Cr
- Net profit (annual)
- ₹12.03 Cr
- P/E (TTM)
- 15.8×Sector 35.5×
- Promoter holding
- 66.88%
- FII holding
- 0.18%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Neochem Bio Solutions Ltd
All →Neochem Bio Solutions Earnings Call Transcript: Key Takeaways
Neochem Bio Solutions is a specialty chemical manufacturer reporting strong H1 FY25 growth, achieving ₹4,718 Lakh income with 18.75% EBITDA margin, focusing on Textile, HPC, and sustainable bio-based formulations.
Neochem Bio Solutions Investor Presentation: Key Takeaways
H1 FY27 revenue ₹68.9 cr (+50% y-o-y), PAT ₹7.8 cr (+43%), but EBITDA margin fell to 18.0% from 21.7%. Strategy centres on diversification and bio-based chemistries.
Neochem Bio Solutions Management Change
Neochem Bio Solutions appointed Harshit Shah as CFO and Vikram Nair as CCO effective October 27. Solanki was redesigned from CFO to Senior VP Finance.
Neochem Bio Solutions H1 FY27 Results: Net Profit ₹7.8 Cr, Up 41.8% YoY
Neochem Bio Solutions Ltd reported revenue from operations of ₹68.9 Cr (+50.4% YoY) and net profit of ₹7.8 Cr (+41.8% YoY) for H1 FY27.
- Key figure
- Net profit ₹7.8 Cr · +41.8% YoY
Neochem Bio Solutions Other Announcement
Neochem Bio Solutions Limited submitted its Structured Digital Database (SDD) compliance certificate for the quarter and half-year ended September 30, 2026, as per SEBI regulations.
Neochem Bio Solutions Annual General Meeting
Neochem Bio Solutions Limited held its 9th Annual General Meeting on September 21, 2026, where management reviewed the company's performance and discussed future business strategies.